Henry George Friesen (born December 31, 1934) is a distinguished Canadian endocrinologist and medical researcher renowned for his groundbreaking work in the field of hormones, particularly the discovery and characterization of human prolactin and his contributions to the understanding of growth hormone. His research significantly advanced the understanding of human reproduction, lactation, and growth, leading to improved diagnostic tools and treatments for various endocrine disorders.
Early Life and Education
Henry Friesen was born in Morden, Manitoba, Canada. He pursued his medical education at the University of Manitoba, where he earned his Doctor of Medicine (MD) degree in 1958. Following his medical degree, he undertook postgraduate training, including a research fellowship at the New England Medical Center in Boston, Massachusetts, which laid the foundation for his illustrious career in endocrinology.Career and Research
Friesen's research career began to flourish in the 1960s. A pivotal moment in his career was the isolation and characterization of human prolactin, a hormone previously known to exist in animals but unconfirmed in humans. This discovery, made in 1970, was a significant breakthrough that elucidated its role in lactation, reproductive function, and certain types of tumors. His work also greatly contributed to the understanding of growth hormone, its regulation, and its impact on human development.Throughout his career, Friesen held numerous prominent positions:
- University of Manitoba: He returned to his alma mater, where he became a Professor and Head of the Department of Physiology, and later served as Professor and Head of the Department of Internal Medicine. Under his leadership, the university became a leading center for endocrinological research.
- Medical Research Council of Canada (MRCC): From 1991 to 2000, Friesen served as the President of the MRCC, which was the precursor to the Canadian Institutes of Health Research (CIHR). During his tenure, he played a crucial role in shaping health research policy in Canada, advocating for increased funding and the establishment of a more integrated and comprehensive national health research strategy. His vision led to the transformation of the MRCC into the CIHR, which adopted a more interdisciplinary approach to health research.
Awards and Recognition
Henry Friesen's exceptional contributions to science and medicine have been recognized with numerous prestigious awards and honors, including:- Order of Canada: Appointed Officer in 1987 and promoted to Companion, the highest level of the Order, in 1998, for his fundamental contributions to medical science and for his leadership in medical research.
- Gairdner Foundation International Award (1977): One of Canada's most distinguished medical research awards, recognizing his work on prolactin and growth hormone.
- Distinguished Scientist Award, The Endocrine Society (1985): A high honor from the world's largest organization of endocrinologists.
- Canadian Medical Hall of Fame: Inducted in 2001, acknowledging his lasting impact on Canadian and global health.
- Fellow of the Royal Society of Canada.
Legacy and Impact
Dr. Henry Friesen's legacy is profound. His scientific discoveries provided critical insights into hormone function, impacting fields from reproductive health to oncology. Beyond his laboratory achievements, his leadership in national health research policy transformed the landscape of medical science in Canada, fostering an environment for innovation and collaboration. His work has undoubtedly contributed to better diagnostic tools, therapeutic strategies, and overall human health worldwide.References
- Information compiled from public records including the Order of Canada citations, Canadian Medical Hall of Fame profiles, and Gairdner Foundation laureate biographies.